ICS, Inc News

Phase 2a study of the IL-4R alpha inhibitor, dupilumab, demonstrated 87% reduction in risk of asthma exacerbations in moderate-to-severe asthma patients with elevated eosinophils Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine Phase 2a study of the IL-4R alpha ... (more)

BANKS are making it harder to get a mortgage, despite claims they are committed to lending a 3.5bn this year.

Intrinsyc Software International, Inc. , a leading provider of solutions for the development of embedded and wireless devices, today announced that the Company will release its fiscal first quarter financial results on Wednesday, May 8, 2013 at 4:00 p.m. Eastern Time .

ICS Software of New York now offers the ability to automatically check PECOS eligibility of referring doctors through their EHR program, SammyEHR.

I understand and agree that subscription and registration on this site constitutes agreement to the site's Terms of Use and Privacy Policy .